Catalyst Wire Dossier Catalyst Wire Dossier

Kuvan (sapropterin dihydrochloride)

sapropterin dihydrochloride · BioMarin Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kuvan (sapropterin dihydrochloride), covering 2016-10-18 to 2016-10-18. Get the full timeline:

Most recent: Clinical Trial Update: Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria [Phase 2]

See pricing